Pfizer working on cold storage issues to ensure temperature integrity

US pharma giant Pfizer is working out elaborate cold storage plans to ensure temperature integrity of its vaccine that requires to be maintained at -70 degree Celsius. Pfizer became the first vaccine maker to seek emergency use authorisation (EUA) from the ...

from Google Alert - Business https://ift.tt/36MUZV6
US pharma giant Pfizer is working out elaborate cold storage plans to ensure temperature integrity of its vaccine that requires to be maintained at -70 degree Celsius. Pfizer became the first vaccine maker to seek emergency use authorisation (EUA) from the ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize